Paul-Adrian Chiroi
Paul-Adrian Chiroi
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 23 Marinescu Street, 400337 Cluj-Napoca, Romania
Adresă de e-mail confirmată pe umfcluj.ro
Citat de
Citat de
Cancer-associated stemness and epithelial-to-mesenchymal transition signatures related to breast invasive carcinoma prognostic
IM Groza, C Braicu, A Jurj, O Zanoaga, R Lajos, P Chiroi, R Cojocneanu, ...
Cancers 12 (10), 3053, 2020
Cellular and molecular profiling of tumor microenvironment and early-stage lung cancer
R Pirlog, P Chiroi, I Rusu, AM Jurj, L Budisan, C Pop-Bica, C Braicu, ...
International journal of molecular sciences 23 (10), 5346, 2022
The role of miR-155 in nutrition: modulating cancer-associated inflammation
O Zanoaga, C Braicu, P Chiroi, N Andreea, NA Hajjar, S Mărgărit, ...
Nutrients 13 (7), 2245, 2021
Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in oral squamous cell carcinoma: a potential biomarkers panel?
O Aghiorghiesei, O Zanoaga, L Raduly, AI Aghiorghiesei, P Chiroi, A Trif, ...
Current issues in molecular biology 44 (4), 1754-1767, 2022
The implications of noncoding rnas in the evolution and progression of nonalcoholic fatty liver disease (Nafld)-related hcc
I Rusu, R Pirlog, P Chiroi, A Nutu, VR Puia, AC Fetti, DR Rusu, ...
International Journal of Molecular Sciences 23 (20), 12370, 2022
Comprehensive analysis of the expression of key genes related to Hippo signaling and their prognosis impact in ovarian cancer
P Kubelac, C Braicu, L Raduly, P Chiroi, A Nutu, R Cojocneanu, ...
Diagnostics 11 (2), 344, 2021
New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs
BO Pirlog, S Ilut, R Pirlog, P Chiroi, A Nutu, DI Radutiu, GD Cuc, ...
Expert Reviews in Molecular Medicine, 1-51, 2023
Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms
E Isacescu, P Chiroi, O Zanoaga, A Nutu, L Budisan, R Pirlog, ...
Antioxidants 12 (2), 407, 2023
C,O‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity
AA Someșan, SM Vieriu, A Crăciun, C Silvestru, P Chiroi, A Nutu, A Jurj, ...
Applied Organometallic Chemistry 36 (3), e6540, 2022
Microarrays and NGS for drug discovery
LA Pop, O Zanoaga, P Chiroi, A Nutu, SS Korban, C Stefan, A Irimie, ...
Drug Design-Novel Advances in the Omics Field and Applications, 2021
Vinorelbine Alters lncRNA Expression in Association with EGFR Mutational Status and Potentiates Tumor Progression Depending on NSCLC Cell Lines’ Genetic Profile
H Alsharoh, P Chiroi, A Nutu, L Raduly, O Zanoaga, I Berindan-Neagoe
Biomedicines 11 (12), 3298, 2023
Identification of a miRNA panel with a potential determinant role in patients suffering from periodontitis
O Baru, L Raduly, C Bica, P Chiroi, L Budisan, N Mehterov, C Ciocan, ...
Current issues in molecular biology 45 (3), 2248-2265, 2023
Non-Coding RNAs and Reactive Oxygen Species–Symmetric Players of the Pathogenesis Associated with Bacterial and Viral Infections
Z Milhem, P Chiroi, A Nutu, M Ilea, M Lupse, O Zanoaga, ...
Symmetry 13 (7), 1307, 2021
Profiling canine mammary tumors: A potential model for studying human breast cancer
LM Gherman, P Chiroi, A Nuțu, C Bica, I Berindan-Neagoe
The Veterinary Journal, 106055, 2023
Distinct Morphological and Molecular Profiles of NAFLD and NAFLD-associated HCC Revealed by Immunohistochemistry and MicroRNA Analysis.
I Rusu, R Pirlog, P Chiroi, A Nutu, L Budisan, VR Puia, C Braicu, ...
Journal of Gastrointestinal & Liver Diseases 32 (3), 2023
Alteration of the miR-21, miR-155 and miR-181a expression level in breast cancer: implications in the immune response and possible prognostic value.
P Chiroi, E Isăcescu, M Groza, C Ciocan, C Bica, OL Pop, C Braicu, ...
Oncolog-Hematolog, 2023
Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts?
R Pirlog, P Chiroi, L Raduly, A Nutu, A Cismaru, I Berindan-Neagoe
Tumor Microenvironment Characterization as a Source of Novel Molecular Biomarkers in Early-stage Lung Cancer
R Pirlog, I Rus, P Chiroi, A Jurj, L Budisan, I Neagoe, D Crisan, ...
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–18